import json, io, os, argparse


def build_rows():
    # 20 paraphrased queries (ASCII quotes to avoid smart-quote issues)
    return [
        {
            "text": "Is there a clinically relevant interaction between adalimumab and afelimomab if they are given together?",
            "head": "drug_adalimumab",
            "rel1": "INTERACTS_WITH",
            "tail1": "drug_afelimomab",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["ADALIMUMAB", "AFELIMOMAB"],
            "require_entities": ["ADALIMUMAB", "AFELIMOMAB"],
        },
        {
            "text": "Does treatment with adalimumab ever lead to hidradenitis suppurativa being reported as a side effect?",
            "head": "drug_adalimumab",
            "rel1": "ADVERSE_EFFECT",
            "tail1": "disease_hidradenitis_suppurativa",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["ADALIMUMAB", "HIDRADENITIS SUPPURATIVA"],
            "require_entities": ["ADALIMUMAB", "HIDRADENITIS SUPPURATIVA"],
        },
        {
            "text": "Do antigens exhibit any interaction with peroxidase enzymes?",
            "head": "drug_antigens",
            "rel1": "INTERACTS_WITH",
            "tail1": "drug_peroxidase",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["ANTIGENS", "PEROXIDASE"],
            "require_entities": ["ANTIGENS", "PEROXIDASE"],
        },
        {
            "text": "Have antigens been implicated in causing inflammatory bowel disease?",
            "head": "drug_antigens",
            "rel1": "ADVERSE_EFFECT",
            "tail1": "disease_inflammatory_bowel_disease",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["ANTIGENS", "INFLAMMATORY BOWEL DISEASE"],
            "require_entities": ["ANTIGENS", "INFLAMMATORY BOWEL DISEASE"],
        },
        {
            "text": "Is bevacizumab known to interact with ramucirumab in any way?",
            "head": "drug_bevacizumab",
            "rel1": "INTERACTS_WITH",
            "tail1": "drug_ramucirumab",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["BEVACIZUMAB", "RAMUCIRUMAB"],
            "require_entities": ["BEVACIZUMAB", "RAMUCIRUMAB"],
        },
        {
            "text": "Can ramucirumab therapy lead to lymphopenia as an adverse event?",
            "head": "drug_ramucirumab",
            "rel1": "ADVERSE_EFFECT",
            "tail1": "disease_lymphopenia",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["RAMUCIRUMAB", "LYMPHOPENIA"],
            "require_entities": ["RAMUCIRUMAB", "LYMPHOPENIA"],
        },
        {
            "text": "Do autoantigens interact with RNA transcripts?",
            "head": "drug_autoantigens",
            "rel1": "INTERACTS_WITH",
            "tail1": "drug_rna_transcript",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["AUTOANTIGENS", "RNA TRANSCRIPT"],
            "require_entities": ["AUTOANTIGENS", "RNA TRANSCRIPT"],
        },
        {
            "text": "Are autoantigens associated with multiple sclerosis as an outcome?",
            "head": "drug_autoantigens",
            "rel1": "ADVERSE_EFFECT",
            "tail1": "disease_multiple_sclerosis",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["AUTOANTIGENS", "MULTIPLE SCLEROSIS"],
            "require_entities": ["AUTOANTIGENS", "MULTIPLE SCLEROSIS"],
        },
        {
            "text": "Is there evidence that carcinogens target or affect phosphotransferases?",
            "head": "drug_carcinogens",
            "rel1": "INTERACTS_WITH",
            "tail1": "drug_phosphotransferases",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["CARCINOGENS", "PHOSPHOTRANSFERASES"],
            "require_entities": ["CARCINOGENS", "PHOSPHOTRANSFERASES"],
        },
        {
            "text": "Do carcinogens play a role in causing melanoma?",
            "head": "drug_carcinogens",
            "rel1": "ADVERSE_EFFECT",
            "tail1": "disease_melanoma",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["CARCINOGENS", "MELANOMA"],
            "require_entities": ["CARCINOGENS", "MELANOMA"],
        },
        {
            "text": "Does DB-67 interact with human TOP1 (topoisomerase I)?",
            "head": "drug_db_67",
            "rel1": "INTERACTS_WITH",
            "tail1": "drug_top1_protein_human",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["DB 67", "TOP1 PROTEIN HUMAN"],
            "require_entities": ["DB 67", "TOP1 PROTEIN HUMAN"],
        },
        {
            "text": "Is DB-67 linked to DNA strand breaks?",
            "head": "drug_db_67",
            "rel1": "ADVERSE_EFFECT",
            "tail1": "disease_dna_strand_break",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["DB 67", "DNA STRAND BREAK"],
            "require_entities": ["DB 67", "DNA STRAND BREAK"],
        },
        {
            "text": "Do pegylated liposomal irinotecan formulations interact with human TOP1?",
            "head": "drug_pegylated_liposomal_irinotecan",
            "rel1": "INTERACTS_WITH",
            "tail1": "drug_top1_protein_human",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["PEGYLATED LIPOSOMAL IRINOTECAN", "TOP1 PROTEIN HUMAN"],
            "require_entities": [
                "PEGYLATED LIPOSOMAL IRINOTECAN",
                "TOP1 PROTEIN HUMAN",
            ],
        },
        {
            "text": "Are DNA strand breaks observed with pegylated liposomal irinotecan exposure?",
            "head": "drug_pegylated_liposomal_irinotecan",
            "rel1": "ADVERSE_EFFECT",
            "tail1": "disease_dna_strand_break",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["PEGYLATED LIPOSOMAL IRINOTECAN", "DNA STRAND BREAK"],
            "require_entities": ["PEGYLATED LIPOSOMAL IRINOTECAN", "DNA STRAND BREAK"],
        },
        {
            "text": "Does alemtuzumab interact pharmacologically with ramucirumab?",
            "head": "drug_alemtuzumab",
            "rel1": "INTERACTS_WITH",
            "tail1": "drug_ramucirumab",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["ALEMTUZUMAB", "RAMUCIRUMAB"],
            "require_entities": ["ALEMTUZUMAB", "RAMUCIRUMAB"],
        },
        {
            "text": "Is lymphopenia a reported effect of alemtuzumab?",
            "head": "drug_alemtuzumab",
            "rel1": "ADVERSE_EFFECT",
            "tail1": "disease_lymphopenia",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["ALEMTUZUMAB", "LYMPHOPENIA"],
            "require_entities": ["ALEMTUZUMAB", "LYMPHOPENIA"],
        },
        {
            "text": "Do antigens interact with acetylcholinesterase?",
            "head": "drug_antigens",
            "rel1": "INTERACTS_WITH",
            "tail1": "drug_acetylcholinesterase",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["ANTIGENS", "ACETYLCHOLINESTERASE"],
            "require_entities": ["ANTIGENS", "ACETYLCHOLINESTERASE"],
        },
        {
            "text": "Is anaphylaxis documented as an adverse event for antigens exposure?",
            "head": "drug_antigens",
            "rel1": "ADVERSE_EFFECT",
            "tail1": "disease_anaphylaxis",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["ANTIGENS", "ANAPHYLAXIS"],
            "require_entities": ["ANTIGENS", "ANAPHYLAXIS"],
        },
        {
            "text": "Do antigens have a known interaction with deoxyribonuclease I?",
            "head": "drug_antigens",
            "rel1": "INTERACTS_WITH",
            "tail1": "drug_deoxyribonuclease_i",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["ANTIGENS", "DEOXYRIBONUCLEASE I"],
            "require_entities": ["ANTIGENS", "DEOXYRIBONUCLEASE I"],
        },
        {
            "text": "Are psoriatic outcomes associated with antigen exposure?",
            "head": "drug_antigens",
            "rel1": "ADVERSE_EFFECT",
            "tail1": "disease_psoriasis",
            "rel2": "",
            "tail2": "",
            "boost_terms": ["ANTIGENS", "PSORIASIS"],
            "require_entities": ["ANTIGENS", "PSORIASIS"],
        },
    ]


def main():
    ap = argparse.ArgumentParser()
    ap.add_argument("--out", required=True)
    args = ap.parse_args()
    os.makedirs(os.path.dirname(args.out), exist_ok=True)
    rows = build_rows()
    with io.open(args.out, "w", encoding="utf-8") as f:
        for j in rows:
            f.write(json.dumps(j, ensure_ascii=False) + "\n")
    print(f"[OK] wrote {len(rows)} -> {args.out}")


if __name__ == "__main__":
    main()
